KC-0918

293T-ADAM9-KO-1A2-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
27155
Home » 293T-ADAM9-KO-1A2-Cell-Line

Background of 293T-ADAM9-KO-1A2-Cell-Line

ADAM9 (A disintegrin and a metalloprotease 9) is a membrane-anchored protein that participates in a variety of physiological functions, primarily through the disintegrin domain for adhesion and the metalloprotease domain for ectodomain shedding of a wide variety of cell surface proteins. ADAM9 influences the developmental process, inflammation, and degenerative diseases. Recently, increasing evidence has shown that ADAM9 plays an important role in tumor biology. Overexpression of ADAM9 has been found in several cancer types and is correlated with tumor aggressiveness and poor prognosis. In addition, through either proteolytic or non-proteolytic pathways, ADAM9 promotes tumor progression, therapeutic resistance, and metastasis of cancers. Therefore, comprehensively understanding the mechanism of ADAM9 is crucial for the development of therapeutic anti-cancer strategies.

Specifications

Catalog NumberKC-0918
Cell Line Name293T-ADAM9-KO-1A2-Cell-Line
Host Cell Line293T
DescriptionStable 293T clone with human ADAM9 gene knockout, No.1A2
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing MediumDMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10% FBS
Selection MarkerN/A
Morphologyepithelial
SubcultureSplit saturated culture 1:5-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

293T-ADAM9-KO-1A2 cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of 293T-ADAM9-KO-1A2 cell line stable clone using PCR sequencing.

Figure 2: Characterization of 293T-ADAM9-KO-1A2 cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of 293T-ADAM9-KO-1A2 cell line stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (DMEM + 10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:5-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Chou CW. et al. An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases. Int J Mol Sci,10 (2020).
  2. Chen-Yuan Lin.et al.ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.Int Scientific Reports,November(2017).
Please enable JavaScript in your browser to complete this form.